The cyclobutane ring has attractive properties as a scaffold in medicinal chemistry but is underused, potentially due to the limited methods available for synthesising highly functionalised cyclobutanes. This short note describes the synthesis of the 1,3-cis disubstituted cyclobutane, methyl (S)-3-((1r*,3R*)-3-((1H-indol-3-yl)methyl)cyclobutane-1-carboxamido)-2-(phenylsulfonamido)propanoate using a one-pot thermal stepwise cycloaddition reaction and its characterisation by NMR spectroscopy and HRMS.
No takes yet. Share an insight, caveat, or question.
Helen M. Sheldrake (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: